The vagus nerve mediates the physiological but not pharmacological effects of PYY3-36 on food intake
Peptide YY (PYY3-36) is a post-prandially released gut hormone with potent appetite-reducing activity, the mechanism of action of which is not fully understood. Unravelling how this system physiologically regulates food intake may help unlock its therapeutic potential, whilst minimising unwanted eff...
Main Authors: | Aldara Martin Alonso, Simon C. Cork, Phyllis Phuah, Benjamin Hansen, Mariana Norton, Sijing Cheng, Xiang Xu, Kinga Suba, Yue Ma, Georgina KC. Dowsett, John A. Tadross, Brian YH. Lam, Giles SH. Yeo, Herbert Herzog, Stephen R. Bloom, Myrtha Arnold, Walter Distaso, Kevin G. Murphy, Victoria Salem |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877824000267 |
Similar Items
-
Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY<sub>3-36</sub>, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats
by: Simon Kloock, et al.
Published: (2024-03-01) -
Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction
by: Elias Haj-Yehia, et al.
Published: (2020-12-01) -
Molecular cloning, identification, and expression analysis of Pyy and its effect on mechanisms regulating appetite in Spotted scat, Scatophagus argus
by: Daniel Assan, et al.
Published: (2023-02-01) -
Liraglutide + PYY<sub>3-36</sub> Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements
by: Valentin Metzner, et al.
Published: (2022-01-01) -
Effect of 8-week aerobic training on lipid profile, PYY3-36, and cortisol levels among obese women
by: Vahid Aari Sarraf, et al.
Published: (2020-12-01)